Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade.
J Am Acad Dermatol
; 88(2): 485-487, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-35738514
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immune Checkpoint Inhibitors
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
J Am Acad Dermatol
Year:
2023
Document type:
Article
Country of publication: